Delta Financial Group, Inc. Bristol Myers Squibb CO Transaction History

Delta Financial Group, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	BUY	$47.98 - $54.4 $112,465 - $127,513	2,344 Added 5.78%	42,880 $2.33 Million
Q4 2023 Jan 18, 2024	SELL	$48.48 - $57.85 $468,316 - $558,831	-9,660 Reduced 19.24%	40,536 $2.08 Million
Q3 2023 Oct 31, 2023	BUY	$57.89 - $64.73 $2.91 Million - $3.25 Million	50,196 New	50,196 $2.91 Million
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $941,887 - $1.07 Million	14,334 Added 43.87%	47,010 $3.26 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $2.24 Million - $2.65 Million	32,676 New	32,676 $2.37 Million

2,407

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $115B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Delta Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Delta Financial Group, Inc. with notifications on news.